Court of Appeals Affirms $16.56 Million Judgment Against Johnson & Johnson in Defective Fentanyl Patch Case

by Eddie Staley, Benzinga Editor
July 7, 2011 3:54 PM | 13 seconds read |
The First District of the Illinois Court of Appeals affirmed a $16.56 million judgment against Johnson & Johnson JNJ subsidiaries Janssen Pharmaceutica Inc. and ALZA Corporation in a wrongful death case involving their Duragesic® fentanyl pain patch.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsLegalHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!